Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. (Q33800456)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. |
scientific article |
Statements
Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma (English)
Magdalena B Wozniak
Raquel Villuendas
James R Bischoff
Carmen Blanco Aparicio
Paloma de La Cueva
Ma Elena Rodriguez
Beatriz Herreros
Maria I Longo
Marta Herrera
Pablo L Ortiz-Romero
4 February 2010